Rosetta Genomics Ltd. — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/562434f0-16bd-4c01-9808-8be4c32cf675/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2016 | $-12.6M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-051919 |
| FY 2015 | $-12.9M | 2015-01-01 – 2015-12-31 | evidence 0001144204-17-051919 |
| FY 2014 | $-14.3M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-016317 |
| FY 2013 | $-13.3M | 2013-01-01 – 2013-12-31 | evidence 0001144204-14-019402 |
| FY 2012 | $-8.3M | 2012-01-01 – 2012-12-31 | evidence 0001144204-13-016989 |
| FY 2011 | $-8.8M | 2011-01-01 – 2011-12-31 | evidence 0001144204-13-016989 |
| FY 2010 | $-13.9M | 2010-01-01 – 2010-12-31 | evidence 0001144204-13-016989 |
| FY 2009 | $14.8M | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-025223 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).